Invention Grant
US09278937B2 Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer
有权
取代的2-咪唑烷酮和2-咪唑啉酮及其在治疗癌症中的应用
- Patent Title: Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer
- Patent Title (中): 取代的2-咪唑烷酮和2-咪唑啉酮及其在治疗癌症中的应用
-
Application No.: US14239150Application Date: 2012-08-10
-
Publication No.: US09278937B2Publication Date: 2016-03-08
- Inventor: Rene C.-Gaudreault , Sebastien Fortin
- Applicant: Rene C.-Gaudreault , Sebastien Fortin
- Applicant Address: CA Quebec
- Assignee: UNIVERSITE LAVAL
- Current Assignee: UNIVERSITE LAVAL
- Current Assignee Address: CA Quebec
- Agency: Sutherland Asbill & Brennan LLP
- International Application: PCT/CA2012/000751 WO 20120810
- International Announcement: WO2013/023274 WO 20130221
- Main IPC: A61K31/4166
- IPC: A61K31/4166 ; C07D233/36 ; C07D233/32
Abstract:
Compounds of formula (I) wherein R1, R4, R8, X and Y as defined herein are provided as useful for the inhibition of certain types of cancer cells, amongst others, breast cancer cells, or for the manufacture of anti-cancer agents.
Public/Granted literature
- US20140315968A1 Substituted 2-Imidazolidinones and 2-Imidazolones and Their Use in the Treatment of Cancer Public/Granted day:2014-10-23
Information query
IPC分类:
